Comerica Securities,Inc. Charles River Laboratories International, Inc. Transaction History

Comerica Securities,Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$197.11 - $250.07 $52,628 - $66,768	267 New	267 $58,000
Q2 2021 Aug 11, 2021	SELL	$294.17 - $371.65 $309,466 - $390,975	-1,052 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$249.67 - $299.48 $3,745 - $4,492	-15 Reduced 1.41%	1,052 $305,000
Q4 2020 Feb 09, 2021	SELL	$222.0 - $252.62 $888 - $1,010	-4 Reduced 0.37%	1,067 $267,000
Q3 2020 Nov 04, 2020	SELL	$175.56 - $226.45 $20,716 - $26,721	-118 Reduced 9.92%	1,071 $243,000
Q2 2020 Jul 17, 2020	BUY	$118.84 - $189.72 $141,300 - $225,577	1,189 New	1,189 $207,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

Stay updated on Comerica Securities,Inc. with notifications on news.